| For: | Li C, Wu MY, Liang YR, Wu XY. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9(11): 2395-2399 [PMID: 14606063 DOI: 10.3748/wjg.v9.i11.2395] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/2395.htm |
| Number | Citing Articles |
| 1 |
Alireza Azani, Malihe Sharafi, Reyhaneh Doachi, Sama Akbarzadeh, Parsa Lorestani, Arash Haji Kamanaj Olia, Zahra Zahed, Hossein Gharedaghi, Haniyeh Ghasrsaz, Hassan Foroozand, Hossein Rahimi, Safa Tahmasebi, Qumars Behfar. Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01771-3
|
| 2 |
Mahendar Porika, Radhika Tippani, Anwar Mohammad, Sekhar R Bollam, Sree D Panuganti, Sadanandam Abbagani. Evaluation of Serum Human Telomerase Reverse Transcriptase as a Novel Marker for Cervical Cancer. The International Journal of Biological Markers 2011; 26(1) doi: 10.5301/JBM.2011.6352
|
| 3 |
Yujuan Kang, Lin Wan, Qin Wang, Yanling Yin, Jiena Liu, Lei Liu, Hao Wu, Lei Zhang, Xin Zhang, Shouping Xu, Da Pang. RETRACTED ARTICLE: Long noncoding RNA SNHG1 promotes TERT expression by sponging miR-18b-5p in breast cancer. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00675-5
|
| 4 |
Ana Pestana, Rui Batista, Ricardo Celestino, Sule Canberk, Manuel Sobrinho-Simões, Paula Soares. Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours. Cancers 2020; 12(7) doi: 10.3390/cancers12071846
|
| 5 |
Utpal Ghosh, Nitai P. Bhattacharyya. Benzamide and 4‐amino 1,8 naphthalimide treatment inhibit telomerase activity by down‐regulating the expression of telomerase associated protein and inhibiting the poly(ADP‐ribosyl)ation of telomerase reverse transcriptase in cultured cells. The FEBS Journal 2005; 272(16) doi: 10.1111/j.1742-4658.2005.04837.x
|
| 6 |
M.L. McCabe, Z. Dlamini. The molecular mechanisms of oesophageal cancer. International Immunopharmacology 2005; 5(7-8) doi: 10.1016/j.intimp.2004.11.017
|
| 7 |
Laura Dioni, Mirjam Hoxha, Francesco Nordio, Matteo Bonzini, Letizia Tarantini, Benedetta Albetti, Alice Savarese, Joel Schwartz, Pier Alberto Bertazzi, Pietro Apostoli, Lifang Hou, Andrea Baccarelli. Effects of Short-Term Exposure to Inhalable Particulate Matter on Telomere Length, Telomerase Expression, and Telomerase Methylation in Steel Workers. Environmental Health Perspectives 2011; 119(5) doi: 10.1289/ehp.1002486
|
| 8 |
Brenna M. McGruder, Donald H. Atha, Wendy Wang, Konrad Huppi, Wen-Qiang Wei, Christian C. Abnet, You-Lin Qiao, Sanford M. Dawsey, Philip R. Taylor, John P. Jakupciak. Real-time telomerase assay of less-invasively collected esophageal cell samples. Cancer Letters 2006; 244(1) doi: 10.1016/j.canlet.2005.12.012
|
| 9 |
Andrew C. Brane, Trygve O. Tollefsbol. Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology. Cells 2019; 8(2) doi: 10.3390/cells8020186
|
| 10 |
Meenu Jain, Shaleen Kumar, Punita Lal, Anu Tiwari, Uday C. Ghoshal, Balraj Mittal. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer. Cancer Detection and Prevention 2007; 31(3) doi: 10.1016/j.cdp.2007.04.005
|
| 11 |
Christina Loukopoulou, Taxiarchis Nikolouzakis, Ioannis Koliarakis, Elena Vakonaki, John Tsiaoussis. Telomere Length and Telomerase Activity as Potential Biomarkers for Gastrointestinal Cancer. Cancers 2024; 16(19) doi: 10.3390/cancers16193370
|
| 12 |
Victoria Gonzalo, Anna Petit, Sergi Castellví-Bel, Maria Pellisé, Jenifer Muñoz, Carme Piñol, Francisco Rodríguez-Moranta, Joan Clofent, Francesc Balaguer, M. Dolores Giráldez, Teresa Ocaña, Anna Serradesanferm, Jaume Grau, Josep M. Reñé, Julián Panés, Antoni Castells. Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease. Gastroenterología y Hepatología 2010; 33(4) doi: 10.1016/j.gastrohep.2009.12.011
|
| 13 |
Mahendar Porika, Radhika Tippani, Sekhar R. Bollam, Sree Divya Panuganti, Christopher Thamidala, Sadanandam Abbagani. Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis. International Journal of Clinical Oncology 2011; 16(6) doi: 10.1007/s10147-011-0230-6
|
| 14 |
Liang Liu, Serene Lai, Lucy G. Andrews, Trygve O. Tollefsbol. Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 2004; 340(1) doi: 10.1016/j.gene.2004.06.011
|
| 15 |
Qiang Xia, Jian-Jun Zhang, Xiao-Yun Tang, Yong Liu, Bei-Ting Huang, Ke-Jian Guo, Yun-Feng Wang. Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth <italic>in vitro</italic>. World Journal of Gastroenterology 2006; 12(25): 4004-4008 doi: 10.3748/wjg.v12.i25.4004
|
| 16 |
Kayla A. Lewis, Trygve O. Tollefsbol. Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms. Frontiers in Genetics 2016; 7 doi: 10.3389/fgene.2016.00083
|
| 17 |
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. TERT biology and function in cancer: beyond immortalisation. Journal of Molecular Endocrinology 2017; 58(2) doi: 10.1530/JME-16-0195
|
| 18 |
Serene R. Lai, Amanda P. Cunningham, Vu Q. Huynh, Lucy G. Andrews, Trygve O. Tollefsbol. Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop. Experimental Cell Research 2007; 313(2) doi: 10.1016/j.yexcr.2006.10.014
|
| 19 |
Mohamed JEMF Mabruk, Cathal O’Flatharta. Telomerase: is it the future diagnostic and prognostic tool in human cancer?. Expert Review of Molecular Diagnostics 2005; 5(6) doi: 10.1586/14737159.5.6.907
|
| 20 |
Hye-Ran Kim, Choong-Won Seo, Keunje Yoo, Sang Jun Han, Jongwan Kim. Yes-associated protein 1 as a prognostic biomarker and its correlation with telomerase in various cancers. Osong Public Health and Research Perspectives 2021; 12(5) doi: 10.24171/j.phrp.2021.0207
|
| 21 |
Haoli Wang, Jianwen Zhou, Qiong He, Yu Dong, Yanhui Liu. Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer. Molecular Medicine Reports 2017; 15(6) doi: 10.3892/mmr.2017.6549
|